Methods
Cancer
CANCER
This single center open label phase II study was conducted at the M Health Fairview Masonic Cancer Clinic. Informed consent was obtained prior to performance of any study related procedures or assessments. The study was reviewed and protocol approved by institutional review board. The study was funded by a supplement to the Masonic Cancer Center’s Cancer Center Support Grant (P30 CA 077598) and registered as clinical trials number NCT00379197. Naltrexone was purchased for use in this trial.